Get 20% lifetime commission for referring investors to digrin.com
here.
Foghorn Therapeutics Inc. ( FHTX) - Key Metrics
FHTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.23 | -$0.10 | -$0.27 | -$0.27 |
| 2026Q1 | $0.05 | -$0.29 | -$0.36 | -$0.36 |
| 2025Q4 | $0.15 | -$0.34 | -$0.35 | -$0.35 |
| 2025Q3 | $0.13 | -$0.25 | -$0.30 | -$0.30 |
| 2025Q2 | $0.12 | -$0.28 | -$0.33 | -$0.33 |
FHTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -12.20 |
| 2026Q1 | 0% | -4.12 |
| 2025Q4 | 0% | -3.86 |
| 2025Q3 | 0% | -4.89 |
| 2025Q2 | 0% | -4.20 |
FHTX
Price: $6.74
52 week price:
Earnings Per Share: -0.99 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 18512
Market Capitalization: 371.8 million